It is noteworthy that although the gene expression signature that was common to the stromal reaction of both breast and prostate carcinoma did not have any survival-predictive value, two individual genes within the common signature, POSTN and RUNX1, were associated with survival of patients with both tumor types. Here, RUNX1 is linked to prostate carcinoma.